Shuttle Pharmaceuticals Provides Corporate Update On Phase 2 Glioblastoma Trial Enrollment, Diagnostics Advancements With UCSF, Launch Of New Corporate Website, And $237,500 Investment By CEO Dr. Anatoly Dritschilo And Other Investors In Recent Financing

BenzingaFeb 26 10:49 ET

Express News | Shuttle Pharmaceuticals FY24 EPS $(3.30) Vs $(3.53) YoY

BenzingaFeb 26 10:48 ET

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

GlobeNewswireFeb 26 10:45 ET

Shuttle Pharmaceuticals | 10-K: Annual report

SECFeb 26 10:22 ET · Announcements

Why Five9 Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

BenzingaFeb 21 05:54 ET

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments

YolowireJan 13 09:18 ET